Pharmaceuticals refer to compounds manufactured for use as a medicinal drug. Companies active in the pharmaceutical industry are involved in development, production and marketing of pharmaceuticals.
The global market for pharmaceuticals is demonstrating a substantial growth in Latin America and Asia, but is relatively stable in Europe. The worldwide market is assessed at about USD 300 billion yearly. The USA, Japan, Germany, France and China are the top pharmaceutical markets. The pharmaceutical industry benefits from the ageing population; new medical discoveries and new drugs approvals; the increased number of chronic, degenerative and heart diseases, and cancer.
The research reports of this Catalogue cover all the major categories within global, regional and local pharmaceuticals markets. The reports offer overviews of the market trends, drivers; factors contributing to market growth. The challenges faced by industry participants, analyses of the top companies involved in the marketplace, and the key market news are provided in the reports.
Publications found:
26,272
Sort by:
Europe Highly Potent API Market By Type (Innovative High-Potency APIs and Generic High-Potency APIs), By Type of Synthesis (Synthetic and Biological), By Therapeutic Area (Oncology, Immunology, Hormonal Disorders, Infectious Diseases, and Others), By Type of Manufacturing (In-House and Outsourced), By End User (Biopharmaceutical & Life Science Companies, Contract Drug Manufacturing Organizations, and Research Institutions), By Country, Competition, Forecast and Opportunities, 2020-2030F
US$ 4,000.00
Europe Highly Potent API Market was valued at USD 6.43 Billion in 2024 and is expected to reach USD 11.02 Billion by 2030 with a CAGR of 9.36% during the forecast period. The Europe Highly Potent Acti...
January 2025
133 pages
Saudi Arabia Antiviral Drugs Market, By Type (Branded, Generics), By Drug Class (DNA Polymerase Inhibitors, Reverse Transcriptase Inhibitors, Protease Inhibitors, Neuraminidase Inhibitors, Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), By Application (HIV, Hepatitis, Herpes, Influenza, Others), By Region, Competition, Forecast & Opportunities, 2020-2030F
US$ 3,500.00
Saudi Arabia Antiviral Drugs Market was valued at USD 505.15 Million in 2024 and is anticipated to project steady growth in the forecast period with a CAGR of 2.39% through 2030. The antiviral drugs m...
January 2025
82 pages
Saudi Arabia Dermatological Drugs Market, By Therapy (Acne, Psoriasis, Rosacea, Alopecia, Others), By Type (Prescription, Over the counter (OTC)), By Route of Administration (Topical Administration, Oral Administration, Parenteral Administration), By Drug Class (Corticosteroids, Retinoids, Antibiotics, Antifungals, Calcineurin Inhibitors, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Others), By Region, Competition, Forecast & Opportunities, 2020-2030F
US$ 3,500.00
Saudi Arabia Dermatological Drugs Market was valued at USD 331.45 Million in 2024 and is anticipated to project impressive growth in the forecast period with a CAGR of 6.85% through 2030. The dermatol...
January 2025
82 pages
Saudi Arabia Pharmaceutical CRO Market, By Type (Drug Discovery, Pre-Clinical, Clinical), By Molecular Type (Small Molecules, Large Molecules), By Service (Project Management/Clinical Supply Management, Data Management, Regulatory/Medical Affairs, Medical Writing, Clinical Monitoring, Quality Management/ Assurance, Biostatistics, Investigator Payments, Laboratory, Patient And Site Recruitment, Technology, Others), By Therapeutics Area (Oncology, CNS Disorders, Infectious Diseases, Immunological Disorders, Cardiovascular Disease, Respiratory Diseases, Diabetes, Ophthalmology, Pain Management, Other), By Region, Competition, Forecast & Opportunities, 2020-2030F
US$ 3,500.00
Saudi Arabia Pharmaceutical CRO Market was valued at USD 236.45 Million in 2024 and is anticipated to project impressive growth in the forecast period with a CAGR of 7.45% through 2030. The pharmaceut...
January 2025
80 pages
Saudi Arabia Topical Drugs Market, By Route of Administration (Dermal Drug Delivery, Ophthalmic Drug Delivery, Rectal Drug Delivery, Vaginal Drug Delivery, Nasal Drug Delivery), By Type (Semi-solid Formulations, Liquid Formulations, Solid Formulations, Transdermal Products), By End User (Home Care Settings, Hospitals & Clinics, Burn Centers, Other), By Region, Competition, Forecast & Opportunities, 2020-2030F
US$ 3,500.00
Saudi Arabia Topical Drugs Market was valued at USD 850.82 Million in 2024 and is anticipated to project robust growth in the forecast period with a CAGR of 4.75% through 2030. A large segment of the...
January 2025
82 pages
Vietnam Ophthalmic Drugs Market By Drug Class (Anti-Allergy, Anti-VEGF agents, Anti-inflammatory, Anti-glaucoma, Gene & Cell Therapy, and Others), By Drug Disease (Dry Eye, Allergies, Glaucoma Infection, Retinal Disorders, Uveitis, Others), By Route Of Administration (Topical, and Local Ocular), By Dosage Type (Gels, Eye solutions & suspensions, Capsules & Tablets, Eye drops, and Ointments), By Region, Competition, Forecast and Opportunities, 2020-2030F
US$ 3,500.00
Vietnam Ophthalmic Drugs Market was valued at USD 478.32 Million in 2024 and is expected to reach USD 824.18 Million by 2030 with a CAGR of 9.45% during the forecast period. The Vietnam ophthalmic dru...
January 2025
83 pages
Global Clinical Trials Support Services Market Size Study, by Service (Clinical Trial Site Management, Patient Recruitment Management, Data Management, Administrative Staff, IRB, Others), Phase (Phase I, Phase II, Phase III, Phase IV), Sponsor (Pharmaceutical & Biopharmaceutical, Medical Devices, Others), and Regional Forecasts 2022-2032
US$ 3,750.00
The Global Clinical Trials Support Services Market, valued at approximately USD 21.3 million in 2023, is projected to expand significantly, growing at a CAGR of 8.00% during the forecast period 2024-2...
January 2025
285 pages
Iron Deficiency Anemia Market - 2025-2032
US$ 3,400.00
Iron Deficiency Anemia Market reached US$ 4.39 billion in 2024 and is expected to reach US$ 7.33 billion by 2032, growing with a CAGR of 6.80% during the forecast period 2026-2032. The Iron Deficiency...
January 2025
48 pages
Global Tumor Necrosis Factor Inhibitor Drugs Market Size Study by Product (Humira, Enbrel, Remicade, Simponi/Simponi Aria, Cimzia, Biosimilars), by Application (Rheumatoid Arthritis, Psoriasis, Ulcerative Colitis, Crohn’s Disease, and Others), by Sales Channel (Hospital Pharmacy, Specialty Pharmacy, Online Pharmacy), and Regional Forecasts 2022-2032
US$ 3,750.00
TNF inhibitors are pivotal in treating autoimmune and inflammatory conditions, including rheumatoid arthritis, psoriasis, and Crohn’s disease, by targeting and inhibiting the action of tumor necrosis...
January 2025
285 pages
Global Artificial Intelligence in Drug Discovery Market Size Study, by Application (Drug Optimization and Repurposing, Preclinical Testing, Others), by Therapeutic Area (Oncology, Neurodegenerative Diseases, Cardiovascular Diseases, Metabolic Diseases, Infectious Diseases, Others), and Regional Forecasts 2022-2032
US$ 3,750.00
The Global Artificial Intelligence (AI) in Drug Discovery Market was valued at approximately USD 1.6 billion in 2023 and is projected to expand at a robust CAGR of 29.7% during the forecast period 202...
January 2025
285 pages
Global Oral Proteins & Peptides Market Size study, by Molecule (Semaglutide, Linaclotide, Calcitonin), by Drug Class (GLP-1 Receptor Agonist, GEP, CGRP), by Therapeutic Area (Diabetes, Gastroenterology, Genetic Disorder), by Formulation (Tablet, Capsule), and Regional Forecasts 2022-2032
US$ 3,750.00
The Global Oral Proteins & Peptides Market is valued at approximately USD 6.03 billion in 2023 and is anticipated to grow at an impressive CAGR of 22.5% over the forecast period 2024-2032, reaching US...
January 2025
285 pages
Global Clinical Trial Investigative Site Network Market Size, Share, Trends Analysis, by Phase (Phase I, Phase II, Phase III, Phase IV), by Therapeutic Areas (Oncology, Cardiology, Pain Management, CNS Conditions, Others), by End Use (Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies, Others) and Regional Forecasts 2022-2032
US$ 3,750.00
The Global Clinical Trial Investigative Site Network Market is poised for substantial growth, projected to reach USD 16.05 billion by 2032, growing at a CAGR of 7.85% during the forecast period. Value...
January 2025
285 pages
Global HIV Clinical Trials Market Size Study, By Phase (Phase I, Phase II, Phase III, Phase IV), By Study Design (Interventional Studies, Observational Studies, Expanded Access Studies), By Sponsor, By Region, and Regional Forecasts 2022-2032
US$ 3,750.00
The global HIV clinical trials market is valued at approximately USD 1.47 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 5.8% over the forecast period 2024-2032. Th...
January 2025
285 pages
Global Post-traumatic Stress Disorder Treatment Market Size study, by Drug Class (Antidepressants, Anti-anxiety, Antipsychotics, Other Drug Class), by Demographics (Adult, Children, Geriatric), by Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Other Pharmacies) and Regional Forecasts 2022-2032
US$ 3,750.00
The global post-traumatic stress disorder (PTSD) treatment market was valued at USD 2.14 billion in 2023 and is anticipated to grow at a compound annual growth rate (CAGR) of 4.08% over the forecast p...
January 2025
285 pages
Chronic Inflammation Treatment Market - 2024-2031
US$ 3,400.00
The Chronic Inflammation Treatment Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to d...
January 2025
56 pages
Global Age-related Macular Degeneration (AMD) Drugs Market Size Study, by Product (Lucentis, Eylea & Eylea HD, Vabysmo, Syfovre), by Molecule (Ranibizumab, Aflibercept, Faricimab), by Approval Type (Biologic, Biosimilar), by Type of AMD, and Regional Forecasts 2022-2032
US$ 3,750.00
The Global Age-related Macular Degeneration (AMD) Drugs Market is currently valued at approximately USD 9.45 billion in 2023 and is forecasted to grow at an impressive CAGR of 10.70% over the forecast...
January 2025
285 pages
Acute Repetitive Seizures Market Size, Share & Trends Analysis Report By Product (USL-261, NRL-1, AZ-002, Diastat Rectal Gel), By Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) And Segment Forecasts, 2025 - 2030
US$ 5,950.00
... hospital. Further key findings from the study suggest: Global acute repetitive seizures market size was estimated at USD 140.5 million in 2017 and is expected to register ...
January 2025
100 pages
OTC Drugs, Medical Devices and Diagnostics: Global Markets
US$ 4,650.00
Report : The current report provides detailed information and estimates through 2029 and market shares for key market players. It details the market size of OTC drugs, medical devices, and diagnostics...
January 2025
139 pages
Active Pharmaceutical ingredient Market Size, Share, and Analysis, By Type (Innovative API and Generic API), By Manufacturer (Captive API Manufacturer and Merchant API Manufacturer), By Synthesis (Synthetic APIs and Biotech APIs), By Application (Cardiovascular Disease, Oncology, Neurological Disorders, Orthopedic Disorders, Respiratory, Urology, and Others), By Region (North America, Europe, Asia-Pacific, and Rest of the World), And Regional Forecast 2024-2034
US$ 5,250.00
Active Pharmaceutical ingredient Market is projected to exhibit a Compound Annual Growth Rate (CAGR) of 6% during the forecast span from 2024 to 2034. In 2023, the market size was assessed at USD 239....
January 2025
646 pages
Clinical Trials Outsourcing Market Size, Share, and Analysis, By Phase (Phase I, Phase II, Phase III, Phase IV), By Application (Cancer, Cardiovascular Diseases, Nervous System Diseases, Infectious Diseases, Musculoskeletal Disease, Gastroenterology Diseases, and Others), By Services Type (Protocol Designing, Site Identification, Patient Recruitment, Laboratory Services, Bioanalytical Testing Services, Clinical Trial Data Management Services, and Others), By End-User (Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies, and Others), By Region (North America, Europe, Asia-Pacific, and Rest of the World), And Regional Forecast 2024-2034
US$ 5,250.00
Clinical Trials Outsourcing Market is projected to exhibit a Compound Annual Growth Rate (CAGR) of 7.1% during the forecast span from 2024 to 2034. In 2023, the market size was assessed at USD 44.4 bi...
January 2025
492 pages
Pharmaceutical Stability And Storage Services Market Size, Share & Trends Analysis Report By Service (Stability, Storage), By Molecule (Large Molecule, Small Molecule), By Region (North America, Europe, Asia Pacific), And Segment Forecasts, 2025 - 2030
US$ 5,950.00
This report can be delivered to the clients within 2 Business Days Pharmaceutical Stability And Storage Services Market Growth & Trends The global pharmaceutical stability and storage services marke...
December 2024
130 pages
Chemistry, Manufacturing And Control Services Outsourcing Market Size, Share & Trends Analysis Report By Type (API, Finished Drug Formulation, Medical Devices), By Service, By End-use, By Region, And Segment Forecasts, 2025 - 2030
US$ 5,950.00
This report can be delivered to the clients within 3 Business Days Chemistry, Manufacturing And Control Services Outsourcing Market Growth & Trends The global chemistry, manufacturing and control se...
December 2024
150 pages
Hemoglobinopathies Market - 2024-2031
US$ 3,400.00
Hemoglobinopathies Marketis is growing with a CAGR of 10.70% during the forecast period 2026-2035. The Hemoglobinopathies Market emerges as a key focus in DataM Intelligence latest in-depth analysis,...
December 2024
44 pages
Focal Segmental Glomerulosclerosis Market - 2024-2031
US$ 3,400.00
Focal Segmental Glomerulosclerosis Marketis is growing with a CAGR of 7.50% during the forecast period 2026-2035. The Focal Segmental Glomerulosclerosis Market emerges as a key focus in DataM Intellig...
December 2024
60 pages
Thalassemia Market - 2024-2031
US$ 3,400.00
The Thalassemia Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to deliver unparalleled...
December 2024
37 pages
Saudi Arabia Pharmaceutical Market - 2024-2031
US$ 1,899.00
Saudi Arabia Pharmaceutical Market reached in and is expected to reach by , growing with a CAGR of 0.00% during the forecast period 2026-. The Saudi Arabia Pharmaceutical Market emerges as a key focus...
December 2024
53 pages
Dermatological Drugs Market Size, Share & Trends Analysis Report By Therapy (Acne, Psoriasis, Rosacea), By Type, By Route Of Administration, By Drug Class, By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2030
US$ 5,950.00
This report can be delivered to the clients within Immediate Dermatological Drugs Market Growth & Trends The global dermatological drugs market size is expected treach USD 42.3 billion by 2030, expa...
December 2024
100 pages
Pharmaceutical Impurity Synthesis And Isolation Services Market Size, Share & Trends Analysis Report By Service (Synthesis Services, Isolation Services), By Impurity Type, By Technique, By Application, By End-use, By Region, And Segment Forecasts, 2025 - 2030
US$ 5,950.00
This report can be delivered to the clients within 3 Business Days Pharmaceutical Impurity Synthesis And Isolation Services Market Growth & Trends The global pharmaceutical impurity synthesis and is...
December 2024
110 pages
Pharmaceutical Regulatory Affairs Market Size, Share & Trends Analysis Report By Service Provider (In-house, Outsourcing), By Service, By Category, By Indication, By Development Stage, By Company Size, By Region, And Segment Forecasts, 2025 - 2030
US$ 5,950.00
This report can be delivered to the clients within 3 Business Days Pharmaceutical Regulatory Affairs Market Growth & Trends The global pharmaceutical regulatory affairs market size is expected treac...
December 2024
150 pages
Membranous Nephropathy Market - 2024-2031
US$ 3,400.00
The Membranous Nephropathy Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to deliver u...
December 2024
48 pages
Renal Insufficiency Market - 2024-2031
US$ 3,400.00
The Renal Insufficiency Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to deliver unpa...
December 2024
45 pages
Synthetic Small Molecule API Market Size, Share & Trends Analysis Report By Manufacturer (In-house, Outsourced), By Application (Oncology, Pulmonology, CNS, Endocrinology), By Region, And Segment Forecasts, 2025 - 2030
US$ 5,950.00
This report can be delivered to the clients within 3 Business Days Synthetic Small Molecule API Market Growth & Trends The global synthetic small molecule API market size is estimated treach USD 257...
December 2024
90 pages
Hyperammonemia Market - 2024-2031
US$ 3,400.00
The Hyperammonemia Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to deliver unparalle...
December 2024
40 pages
Small Molecule API Market Size, Share & Trends Analysis Report By Type (Synthetic, Biotech), By Manufacturer, By Application (Oncology, Pulmonology, CNS, Endocrinology), By Region, And Segment Forecasts, 2025 - 2030
US$ 5,950.00
This report can be delivered to the clients within 2 Business Days Small Molecule API Market Growth & Trends The global small molecule API market size is expected treach USD 297.0 billion by 2030, e...
December 2024
100 pages
